Literature DB >> 22083981

Traditional Chinese medicine syndrome distribution in chronic hepatitis B populations: a systematic review.

Xiao-Xi Zeng1, Zhao-Xiang Bian, Tai-Xiang Wu, Shu-Fei Fu, Eric Ziea, Wong Taam Chi Woon.   

Abstract

Many patients with chronic hepatitis B (CHB) seek help from traditional Chinese medicine (TCM). TCM treatment is based on syndrome differentiation. This study aimed to investigate the syndrome distribution in populations of CHB patients. The pre-specific search strategy was set, and 93 studies (20,106 participants) were identified by electronic and hand searches. The methodological quality of included studies was assessed. Data on syndrome distribution and correlations between syndromes and severity of CHB, were extracted and analyzed. Forty-seven syndromes were identified under 24 different syndrome diagnosis systems for CHB. The majority of included studies reported Liver Depression and Spleen Deficiency (LDSD) (52.54% of studies) or Liver-Gallbladder Dampness Heat (LGDH)/Dampness-Heat Obstructing Middle Energizer (DHME) (32.20%) as the major syndromes in CHB patients without cirrhosis. Pooled analysis revealed that LDSD and LGDH/DHME accounted for 61.19% of participants without cirrhosis. In addition, Liver-Kidney Yin Deficiency (LKYinD) (40.99%) and Spleen-Kidney Yang Deficiency (SKYangD) (40.43%) syndromes were common in patients with severe CHB. The percentage of patients with Blood Stasis syndrome increased as the disease progressed to cirrhosis (32.09%). To conclude, LDSD and LGDH/DHME syndromes are found in a significant majority of CHB patients, particularly in the early stages. LKYinD, SKYangD and Blood Stasis dominate in patients at more advanced stages. More epidemiological studies of high methodological quality on syndrome distribution in CHB and standardization of syndrome differentiation for CHB are required to confirm the trends indicated by the studies reviewed here; confirming these trends can increase the efficacy of treatment and give guidance to doctors.

Entities:  

Mesh:

Year:  2011        PMID: 22083981     DOI: 10.1142/S0192415X11009408

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  10 in total

1.  Herbal medicines as adjuvants for cancer therapeutics.

Authors:  Chong-Zhi Wang; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2012       Impact factor: 4.667

2.  Current research and future directions in pattern identification: Results of an international symposium.

Authors:  Myeong Soo Lee; Ju Ah Lee; Terje Alraek; Zhao-Xiang Bian; Stephen Birch; Hirozo Goto; Jeeyoun Jung; Shung-Te Kao; Sang-Kwan Moon; Bongki Park; Kyung-Mo Park; Sooseong You; Kyung-Jin Yun; Chris Zaslawski
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

3.  Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.

Authors:  Yanhao He; Qiang Liu; Yanxiang Li; Xiaofeng Yang; Weirong Wang; Tingting Li; Wei Zhang; Yuexin Cui; Chaoyun Wang; Rong Lin
Journal:  J Physiol Biochem       Date:  2015-01-28       Impact factor: 4.158

4.  Key symptoms selection for two major syndromes diagnosis of Chinese medicine in chronic hepatitis B.

Authors:  Yu Zhao; Hong Kang; Jing-Hua Peng; Lin Xu; Zhi-Wei Cao; Yi-Yang Hu
Journal:  Chin J Integr Med       Date:  2016-05-25       Impact factor: 1.978

5.  Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis.

Authors:  Zhizhong Guo; Shuhao Yu; Yan Guan; Ying-Ya Li; Yi-Yu Lu; Hui Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-30       Impact factor: 2.629

6.  Active Ingredients and Action Mechanisms of Yi Guan Jian Decoction in Chronic Hepatitis B Patients with Liver Fibrosis.

Authors:  Guangyao Li; Yuan Zhou; Daniel Man-Yuen Sze; Chao Liu; Qianru Zhang; Zihao Wang; Hua Yu; Ging Chan; Zhongdao Wu; Shibing Su; Yuanjia Hu
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-03       Impact factor: 2.629

7.  HLA-DQB1/DRB1 Alleles Associate with Traditional Chinese Medicine Syndrome of Chronic Hepatitis B: A Potential Predictor of Progression.

Authors:  Xiyang Liu; Tingjun Wan; Sijie Dang; Dong Wang; Cen Jiang; Yue Su; Mengmeng Shen; Xuchen Tang; Xia Li; Baixue Li; Li Wen; Quansheng Feng
Journal:  Biomed Res Int       Date:  2019-11-21       Impact factor: 3.411

8.  Acupuncture Based on Regulating Autonomic Nerves for the Prevention of Migraine Without Aura: A Prospective, Double-Dummy, Randomized Controlled Clinical Trial.

Authors:  Chuanlong Zhou; Jie Bao; Hantong Hu; Siting Ye; Xiaomei Shao; Yi Liang; Jianqiao Fang
Journal:  J Pain Res       Date:  2022-08-04       Impact factor: 2.832

Review 9.  Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.

Authors:  Zhijia Zhou; Jinghao Zhang; Liping You; Tao Wang; Kaixia Wang; Lingtai Wang; Xiaoni Kong; Yueqiu Gao; Xuehua Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

10.  Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data.

Authors:  Qi-Long Chen; Yi-Yu Lu; Gui-Biao Zhang; Ya-Nan Song; Qian-Mei Zhou; Hui Zhang; Wei Zhang; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-16       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.